Next Article in Journal
Optimizing PSMA Radioligand Therapy for Patients with Metastatic Castration-Resistant Prostate Cancer. A Systematic Review and Meta-Analysis
Next Article in Special Issue
IP3R Channels in Male Reproduction
Previous Article in Journal
Kisspeptin Influences the Reproductive Axis and Circulating Levels of microRNAs in Senegalese Sole
Previous Article in Special Issue
Regulation of Male Fertility by the Renin-Angiotensin System
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
IJMS
Volume 21
Issue 23
10.3390/ijms21239053
ijms-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Molecular Regulation of Copper Homeostasis in the Male Gonad during the Process of Spermatogenesis

by
Sylwia Herman
1,
Paweł Lipiński
2,
Mateusz Ogórek
1,
Rafał Starzyński
2,
Paweł Grzmil
1,
Aleksandra Bednarz
1 and
Małgorzata Lenartowicz
1,*
1
Department of Genetics and Evolution, Institute of Zoology and Biomedical Research, Jagiellonian University, Gronostajowa 9, 30-387 Kraków, Poland
2
Department of Molecular Biology, Institute of Genetics and Animal Biotechnology, Polish Academy of Sciences, 05-552 Magdalenka, Jastrzębiec, Poland
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2020, 21(23), 9053; https://0-doi-org.brum.beds.ac.uk/10.3390/ijms21239053
Submission received: 1 November 2020 / Revised: 23 November 2020 / Accepted: 25 November 2020 / Published: 28 November 2020
(This article belongs to the Special Issue Trace Elements and Male Fertility)
Browse Figures
Versions Notes

Abstract

:
Owing to its redox properties, copper is a cofactor of enzymes that catalyze reactions in fundamental metabolic processes. However, copper–oxygen interaction, which is a source of toxic oxygen radicals generated by the Fenton reaction, makes copper a doubled-edged-sword in an oxygen environment. Among the microelements influencing male fertility, copper plays a special role because both copper deficiency and overload in the gonads worsen spermatozoa quality and disturb reproductive function in mammals. Male gametes are produced during spermatogenesis, a multi-step process that consumes large amounts of oxygen. Germ cells containing a high amount of unsaturated fatty acids in their membranes are particularly vulnerable to excess copper-mediated oxidative stress. In addition, an appropriate copper level is necessary to initiate meiosis in premeiotic germ cells. The balance between essential and toxic copper concentrations in germ cells at different stages of spermatogenesis and in Sertoli cells that support their development is handled by a network of copper importers, chaperones, recipient proteins, and exporters. Here, we describe coordinated regulation/functioning of copper-binding proteins expressed in germ and Sertoli cells with special emphasis on copper transporters, copper transporting ATPases, and SOD1, a copper-dependent antioxidant enzyme. These and other proteins assure copper bioavailability in germ cells and protection against copper toxicity.

1. Introduction

Copper (Cu) is a trace element necessary for the growth and development of all living organisms and is the third most abundant trace element in the body after iron and zinc [1]. In an organism, this reactive element can exist in two oxidation states: as a reduced, cuprous (Cu+) and as an oxidized, cupric (Cu2+) ion [2]. The extensive range of redox potentials of copper and its capacity to participate in one-electron transfer reactions determine the biological activity and function of this microelement. Owing to its redox properties, copper is a cofactor for more than 30 enzymes. Many Cu-dependent enzymes catalyze reactions used in fundamental metabolic processes including respiration (cytochrome c oxidase), detoxication of oxygen free radicals (superoxide dismutases: SOD1 and SOD3), connective tissue formation (lysyl oxidase), neurotransmitter synthesis (dopamine ß-hydroxylase and peptidylglycine-amidating monooxygenase, PAM), pigment production (tyrosinase), and iron metabolism (ceruloplasmin and hephaestin) [3,4,5]. Copper also takes part in the processes of myelination and regulation of the circadian rhythms, and is necessary for angiogenesis and coagulation [6]. Copper deficiency leads to the impaired function of these enzymes and in consequence to disturbances in the key metabolic processes. Conversely, by means of the same redox activity, copper can generate an extremely harmful hydroxyl radical (·OH) through the Fenton reaction [7], which may cause oxidative damage to proteins and nucleic acids, lipid peroxidation, and enzyme inhibition. For this reason, excess copper is highly toxic to organisms [2,3,7]. To deal with this dual nature of copper, tightly regulated molecular mechanisms have evolved and operate in organisms to ensure its bioavailability and to reduce its toxicity. The balance between essential and toxic copper concentrations at both cellular and systemic levels is maintained by a complex network of proteins involved in the regulation of copper uptake, transport, utilization, storage, and excretion.

2. An Outline of Systemic Copper Metabolism in Mammals

In adult mammals, copper is predominantly absorbed in the duodenum and small intestine and is transported to the blood from enterocytes. In adult humans, the average daily intake of copper ranges from 0.8 to 3 mg [3,4,8]. In the blood, absorbed copper is bound to albumin, histidine, or glutathione, and is then transported via the portal vein into the liver, a central organ that maintains copper homeostasis [3,4]. In hepatocytes, copper is bound to ceruloplasmin (CP) and is again excreted to the circulatory system, and with blood redistributed to other organs and tissues [9,10]. CP is a main copper carrier in the blood, transporting this microelement to various organs and tissues. Approximately 90% of serum copper occurs in the complex with CP, while the remaining 10% is bound to albumin or amino acids [4]. Copper, when delivered to various organs, is utilized in metabolic processes by Cu-containing enzymes. Although various tissues differ in copper requirements, the set of proteins regulating copper distribution within the cells is thought to be the same in all tissues. On the other hand, excess cytosolic copper in hepatocytes is expelled into the bile and removed from the organism in feces. Only 2% of copper is removed from the body by the kidneys in urine [4,11,12].

3. Cellular Copper Uptake, Transport, and Utilization Are Orchestrated by a Closely Integrated Network of Proteins

Over the last three decades, a remarkable increase has been made in our understanding of the molecular mechanisms of copper homeostasis, as well as the structure and function of Cu-containing proteins. A real breakthrough was the discovery in 1993 of ATP7A and ATP7B proteins: Cu-transporting ATPases [13,14,15,16]. Currently, we know that cellular copper homeostasis requires a series of copper importers, carriers, chaperones, recipient proteins, and exporters to achieve the essential level of this biometal and prevent its toxicity (summarized in Figure 1). Cellular copper uptake, transport, and utilization are coordinated by a closely integrated network of three groups of proteins.
The first group comprises copper transporters belonging to the CTR/SLC31 (copper transporter) family: CTR1 and CTR2 proteins that are involved in copper uptake and intracellular distribution. In mammalian cells, copper import is primarily mediated by the high-affinity copper membrane transporter CTR1 (more than 80% of intracellular copper import is CTR1-dependent). Although CTR1 is ubiquitously expressed in tissues, its expression is especially high in the liver, kidneys, small intestine, ovaries, testes, and heart [17,18,19,20,21,22]. CTR2, a second cellular copper transporter, exhibits exclusively intracellular localization. CTR2 is localized in the membranes of the vacuoles, vesicles, endosomes, and lysosomes of mammalian cells [17,20,23]. The major role of CTR2 is to facilitate copper release from degraded cuproenzymes in lysosomes and to transport it back into the cytosol for reutilization [17,20].
The second group comprises metallochaperones, cytosolic copper transporters that bind Cu ions and deliver them to the cellular organelles to prevent possible participation of Cu ions in the Fenton reaction [7,18]. These metallochaperones include among others an antioxidant 1 protein (ATOX1), which binds Cu+ ions and transports them from the Golgi apparatus to ATP7A and ATP7B proteins [3,7,24]. ATOX1-ATP7A and ATOX1-ATP7B interactions are essential for intracellular copper translocation and trafficking because ATOX1 also regulates the catalytical activities of both ATPases [24,25]. The copper chaperone for superoxide dismutase 1 (CCS) is a ubiquitously expressed cytosolic metallochaperone, delivering Cu ions to Cu,Zn-SOD1 molecules in the cytoplasmic reticulum. By means of this function, CCS is responsible for the conversion of apo-SOD1 to the active holoenzyme [26,27,28,29]. Cytochrome c oxidase copper chaperone (COX17) is a metallochaperone that binds Cu ions and transports them to mitochondria, where they are bound to subunits of cytochrome-c oxidase, an enzyme of complex IV of the mitochondrial respiratory chain. COX17 is a small, hydrophilic protein located in the cytoplasm and mitochondrial intramembrane space. COX17 is expressed in all tissues [30,31].
The third group comprises P-type Cu-transporting ATP-ases (ATP7A and ATP7B), localized in the trans-Golgi network (TGN). In the Golgi apparatus, ATP7A and ATP7B proteins transfer copper, using the energy of ATP hydrolysis, into the lumen of the secretory pathway where this metal is incorporated into the active sites of the Cu-dependent enzymes. Both ATP7A and ATP7B are also involved in the ATP-dependent transport of Cu ions across the plasma or intracellular membranes [3,17,25,32]. ATP7A and ATP7B are encoded by different genes localized in separate chromosomes. In humans and laboratory rodents, ATP7A protein is encoded by the X-linked ATP7A (Atp7a in rodents) gene and its expression has been reported in nearly all cells in the body [13,14,15]. For this reason, ATP7A is considered to be a housekeeping gene. Nevertheless, its expression differs among the cells and tissues and is age-dependent [3,9,10,33]. The highest expression levels have been found in the brain, kidney, small intestine, and heart [3,34,35,36]. In humans, lack of ATP7A activity caused by a mutation in the ATP7A gene leads to severe metabolic syndrome—Menkes disease [1].
ATP7B is encoded by the autosomal ATP7B gene. In humans the ATP7B gene is located on chromosome 13, in mice on chromosome 8 [16,37,38]. In mammals, ATP7B protein is primarily synthesized in the liver in the hepatocyte, but its expression has been also reported in other tissues such as the placenta, mammary gland, eye, lung, and brain [3,16,38]. ATP7B protein in hepatocytes is responsible for copper binding to apo-ceruloplasmin, resulting in the formation of the redox-active holo-ceruloplasmin, responsible for the transport of copper into the bloodstream. ATP7B also participates in the excretion of excess copper to the bile [39]. Besides the liver, ATP7B is also responsible for the return transport of copper from the placenta to the maternal compartment, to prevent excess copper accumulation in the fetus [40,41]. During lactation in mammary gland cells, ATP7B expression exhibits a granular, diffuse cytoplasmic pattern, and participates in copper export to the milk [42]. Mutation in the ATP7B gene results in disturbances in copper binding to ceruloplasmin (CP) by the ATP7B protein and leads to copper accumulation in the liver up to the toxic level in patients with Wilson disease [3,43]. In cells, ATP7A and ATP7B are found predominantly in membranes of the TGN and endocytic vesicles, and to a lesser extent at the plasma membrane. ATP7A and ATP7B circulate between these compartments in response to changes in intracellular copper levels. The Cu-dependent regulation of intracellular localization of ATPases determines the fate of this metal, which is either used for the biosynthesis of Cu-dependent enzymes in the secretory pathway or is sequestered in or released from vesicles into the extracellular milieu [25,38]. By means of different mechanisms, both ATP7A and ATP7B prevent toxic copper accumulation by expelling Cu ions from the cells. When the cells are exposed to increased copper concentrations, ATP7A moves to the cytoplasm and plasma membrane (in polarized cells to the basolateral membrane) [17,32,38,44]. Under the same conditions, ATP7B is transported to the plasma membrane in vesicles (in polarized cells to the apical membrane) [2,25,38]. It has been proposed that this Cu-induced trafficking of both ATPases is fundamental for maintaining cellular copper homeostasis [3]. Another important role of ATP7A involves delivering of Cu+ ions to the secretory pathway where they are incorporated into the Cu-dependent enzymes such as lysyl oxidase, tyrosinase, dopamine-β-hydroxylase, peptidylglycine-α-amidating monooxygenase, and extracellular dismutase (SOD3) [3,45,46].

4. Dysfunction of Spermatogenesis in Both Copper Overload and Deficiency

Although our knowledge of the molecular regulation of copper metabolism has dramatically increased over the past 30 years, the precise molecular mechanisms of copper handling in the male reproductive system are still poorly understood. Moreover, available clinical data urgently wait for a better explanation of the regulation of copper acquisition and distribution within cells of the male reproductive system. Results of numerous human and animal studies indicate that both testis structure and the process of spermatogenesis (production, maturation, motility, and fertilizing capacity of the spermatozoa) are affected in response to increased copper concentration [47,48,49,50,51,52,53,54]. It has been also reported that seminal plasma copper concentrations in oligozoospermic, asthenozoospermic, and azoospermic patients are significantly higher than in normozoospermic individuals [55]. Even in infertile men, exposure to high environmental copper concentration is associated with increased oxidative stress manifested by the increased total oxidant value in the seminal plasma [56]. Clinical manifestations associated with copper poisoning such as seminiferous tubule epithelium degradation [48,54], reduction in spermatozoa number [49], decreased spermatozoa motility [48,56], acrosome reaction inhibition [57], and increased apoptosis have been reported to reduce male fertility [47,48]. Moreover, decreased testosterone levels have been noticed in rats supplemented with a high copper diet [49]. In young male mice injected with small amounts of cupric chloride (CuCl2), the development of gonads was delayed in comparison to control mice [48]. In addition, in infertile and subfertile men, blood serum and seminal plasma copper concentrations were significantly higher than those in the fertile controls [28,53,54]. Conversely, there is strong evidence showing that Cu-deficient ram, rat, mouse, and goat males produce ejaculates of lower volume, lower spermatozoa concentration, poorer spermatozoa motility, and morphology. Histological analyses have demonstrated that the seminiferous tubules of Cu-deficient animals are less developed. This was mainly explained by the inactivation of the function of the Sertoli cells [48,50,58,59,60,61]. All these data indicate that copper concentration and metabolism in male gonads must be very tightly regulated, starting from puberty and continuing progressively throughout adult life. Studies using the mouse model showed that in adult males, copper concentration in the testes (0.94 μg/g wet tissue) [48] is lower in comparison with other organs such as the brain (1.5 μg/g) [62], kidney (4.4 μg/g), and liver (4.94 μg/g) [10,12].

5. High-Affinity Copper Proteins from the CTR Family Facilitate Copper Transport to Both Sertoli and Germinal Cells

Copper is transported from the blood to the gonads and is distributed all over the organ through the capillary vessels. Up to now, it is unclear how copper is delivered from capillary vessels to seminiferous tubules. Importantly, seminiferous tubules are penetrated by neither blood nor lymph vessels. In rodents, seminiferous tubules are closely surrounded by tunica propria composed of fibroblasts and the myoid cell layer (shown in Figure 2) [63]. Many transporters expressed either in Sertoli cells or germinal cells act to facilitate the influx and/or efflux of metabolites and create a suitable environment for spermatogenesis [63,64]. The results of our recent study indicate an age-dependent regulation of the expression of copper transporter genes Slc31a1 and Slc31a2 (encoding CTR1 and CTR2 proteins, respectively) in the mouse immature and mature male gonads [65]. CTR1 transports copper in the form of Cu+ ions in an ATP-independent manner using conserved methionine residues located in the N-terminal domain. Two-dimensional electron microscopy studies have demonstrated that CTR1 forms a pore for the movement of Cu+ ions across membranes by the formation of homotrimers within the cell membrane [20,21]. Studies on mouse models provide evidence that within the seminiferous tubules of adult males, high-affinity copper transporter CTR1 mediates copper transport to both Sertoli cells and germinal cells [19,64,65]. In the cross-section of the testis, the expression of CTR1 has been detected in spermatogonial cells and primary spermatocytes [64,65]. Therefore, it seems that CTR1 plays a major role in the supply of copper to premeiotic and early meiotic germinal cells. In addition, our findings revealed that in the mouse testis, expression of the Slc31a1 gene gradually increases from postnatal day 10 up to day 18 and its highest expression occurs between postnatal days 18 and 22, when the primary spermatocytes are the most abundant cells in the seminiferous tubules. In the testes of 30-day-old males, a significant reduction in Slc31a1 gene expression was detected, indicating that it is lower when postmeiotic cells constitute a significant proportion of germ cells. This indicates that CTR1 supplies premeiotic and early meiotic germinal cells with copper necessary for maintenance of the meiosis process [65]. To examine the functional significance of CTR1 for the process of spermatogenesis, mice with conditional knock-out of the Slc31a1 gene in the germinal cells (CTR1ΔGC mice) were generated [64]. In CTR1ΔGC males, a marked reduction in the size of the testes was observed in the postnatal days 28 and 41. Histological evaluation of testes in CTR1ΔGC mice revealed that in the seminiferous tubules of 28-day-old males the number of primary pachytene spermatocytes was strongly reduced. The presence of germ cells with condensed nuclei in the testes of CTR1ΔGC mice strongly suggested that primary spermatocytes died through apoptosis [64]. In the seminiferous tubules of the 41-day-old CTR1ΔGC males, the majority of germ cells died, while spermatogonia and Sertoli cells were still present. All these data indicate that CTR1 expression in primary spermatocytes is critical for the process of spermatogenesis because it delivers large amounts of copper necessary for the correct course of meiotic division. Our results confirmed these observations and showed that during spermatogenesis progression in mouse gonads, copper concentration increases continuously, reaching the highest value at postnatal day 20, when meiotic germ cells are most prominent [65].
It is noteworthy that the Ctr1 gene is conservative in eukaryotes. Both yeast (Schizosaccharomyces pombe, S. pombe) and insect (Drosophila melanogaster) models highlight the importance of the Ctr protein in the import of copper to germinal cells during the process of meiosis. In yeast, the four proteins Ctr4, Ctr5, Ctr6, and Mfc1 have been identified and characterized as copper transporters operating in meiotic cells. Among them, Ctr4, Ctr5, and Ctr6 are members of the CTR family of membrane copper transporters [66,67,68]. It has been shown that in S. pombe during meiosis the copper transporters Ctr4 and Ctr5 co-localize at the plasma membrane of zygotic cells shortly after the induction of meiosis under low copper conditions and play a critical role in the acquisition of this microelement from the environment [66,68]. In turn, Ctr6 localizes to vacuolar membranes in early meiosis and then undergoes redistribution in a time-dependent manner to reach forespore membranes where it persists until sporulation [66,68]. Ctr6 serves to mobilize intravacuolar stores of copper and participates in the delivery of copper to Sod1, a cytosolic Cu-dependent antioxidant enzyme in yeast [66,68]. In S. pombe the Mfc1 protein, a yeast homolog of mammalian CTR1, is necessary for the progression of meiotic cells through the first prophase. Importantly, functional similarities between yeast Mfc1 and mammalian CTR1 proteins have been demonstrated [69]. Mfc1 is produced throughout the meiotic division and spore maturation process. Mfc1 localizes in the surrounding of the forespore membrane and its presence is required for copper accumulation into forespores and production of fully active copper amine oxidases [66,69]. Cells with a deficiency of Mca1 protein, an activator of Mfc1 gene transcription, are arrested at the first metaphase under Cu-deficient conditions [70]. Thus, it seems that a minimal copper level must be maintained to assure meiotic cell division in yeast. It is tempting to propose that a similar regulatory mechanism might act in mammalian meiotic cells.
In Drosophila melanogaster three Ctr1-like genes are expressed: Ctr1A, Ctr1B, and Ctr1C. The Ctr1A gene is constitutively and ubiquitously expressed. Its loss results in developmental arrest and in a general failure of Cu-dependent processes (cuproenzyme activity, neuropeptide maturation, heart function). The Ctr1B gene is responsible for copper uptake from the intestine. The Ctr1C gene has been proved to be necessary for copper transport into male germ cells. Results of immunohistochemical analysis revealed that its expression is restricted to the male germline cells. In the male gonads of wandering third instar larvae, Ctr1C expression has been found in spermatocyte cysts, and the Ctr1 immunopositive signal gradually became stronger from early to late spermatocyte cysts [71]. Confocal analysis showed that the Ctr1C protein localizes to the plasma membranes of late spermatocyte cysts but is absent from early cysts, and this indicates that copper is delivered to the male meiotic germ cells. In the gonads of mature D. melanogaster males, Ct1rC protein is localized in the mature spermatozoa. Interestingly, loss of function of the Ctr1C gene in D. melanogaster male mutants (Ctr1C6D) did not lead to infertility. However, double male mutants lacking functional Ctr1B and Ctr1C proteins, in which the intraorganismal copper level is strongly reduced due to the impairment of intestinal absorption of the metal (caused by a mutation in the Ctr1B gene) are sterile [71]. All these data attest to the requirement of CTR/Ctr proteins for copper transport to the male germ cells during spermatogenesis and show that this process is very conservative between yeast, insects, and mammals and that copper delivery to the developing male germ cells is critical for the finishing meiosis.
In the mouse testis, apart from germ cells, expression of the Slc31a1 gene has also been reported in somatic cells such as Sertoli cells [19,64,65]. In the seminiferous tubules, Sertoli cells support, nourish, and protect spermatogenic cells using various signal pathways. In addition, tight junctions between adjacent Sertoli cells form a blood–testis barrier (BTB), building an environment optimal for the development of germ cells. The BTB regulates the free transport of metabolites, ions or harmful substances from entering the lumen of the seminiferous tubules and reaching the meiotic germ cells [63,64]. Immunohistochemical analysis has shown that CTR1 protein is localized along both the basal and adluminal compartments of the Sertoli cells [64,65]. To examine whether the loss of the Slc31a1 gene expression in Sertoli cells affects spermatogenesis, mice with specific disruption of this gene in these cells (CTR1ΔSC males) were generated. Interestingly, in CTR1ΔSC males copper concentration in the testes was reduced by about 40% [64]. This strongly suggests that copper can be delivered to the seminiferous tubules via the Sertoli cells equipped with basally localized CTR1. Copper deficiency in the gonads of CTR1ΔSC males also leads to decreased activity of cytochrome c oxidase by up to 60% compared to that in the testes of wild-type (WT) males [64]. Despite the reduction in copper concentration in the gonads of CTR1ΔSC males, these animals were fertile. Moreover, when they were crossed with WT females to assess their fertility, no changes in the length of conception and the number of pups in the litter were observed [64]. In our studies, we also observed the CTR1 immunopositive signal in the lateral membrane of Sertoli cells, localized close to the lumen of seminiferous tubuli [65]. We hypothesized that such localization of CTR1 protein in the Sertoli cells allows reabsorption of Cu+ ions removed from the germinal cells by ATP7A and ATP7B copper transporters. The expression and function of the CTR1 protein in male mouse gonads is summarized in Table 1.
Little is known about the role of the CTR2 protein, a low-affinity cellular Cu+ ion importer involved in the maintenance of copper homeostasis in the gonads. To check whether this protein is also involved in copper import into primary spermatocytes, we analyzed the testicular temporal expression profile of the Slc31a2 gene [65]. Results of the qRT-PCR analysis showed the lowest expression of this gene in the testes of 5- to 22-day-old males, but in 30-day-old and older animals, a significant increase in the Slc31a2 gene expression was observed. Our findings indicate that this gene is predominantly expressed when postmeiotic cells are abundant in the testes of mice [65]. The role of the CTR2 protein during spermatogenesis needs future investigation.

6. Complex Regulation of the Sod1 Gene Encoding Cu,Zn-Superoxide Dismutase (SOD1) in Male Gonads

For many years it has been believed that among various mammalian cell types, male germ cells are particularly vulnerable to excess copper [72,73]. Spermatogenesis is a process that consumes large amounts of oxygen. Testes are very susceptible to the reactive oxygen species due to the high content of unsaturated fatty acids in the membranes of testicular cells [74]. The ability of copper to react with partially reduced forms of O2 such as the superoxide anion (O2−) and hydrogen peroxide (H2O2) may lead to the formation of the hydroxyl radical (OH), a highly destructive oxidant [74,75]. The first enzyme involved in the protection against oxidative damage is SOD1, which catalyzes the conversion of O2− to H2O2 and O2 dismutation. Then, H2O2 is metabolized by catalase (CAT) or, to a greater extent, by glutathione peroxidase (GPX) [74,76]. In mammalian somatic cells, SOD1 protein is responsible for approximately 90% of total SOD (superoxide dismutase) activity [75]. In the male gonads, the Sod1 gene exhibits a specific and unusual expression pattern. In mouse testes, three alternative transcripts, (0.73, 0.80, and 0.93 kb), of the Sod1 gene have been found [77]. In somatic cells of the gonad, the 0.73 kb Sod1 (somatic, sSod1) transcript is synthesized whereas the 0.80 and 0.93 kb Sod1 (testicular, tSod1) transcripts are specific only for the germ cells [77]. The sSod1 and tSod1 transcripts differ in 5′UTR (untranslated region on the 5’) structure [77]. The tSod1 transcripts contain an additional 114 nucleotides in the 5′UTR as compared with the sSod1 transcript [77].
In contrast to sSod1, tSod1 is translationally regulated during spermatogenesis. In testes, SOD1 translation is repressed in meiotic cells and SOD1 protein was found only in spermatogonia [73]. It has been proposed by Gu and Hecht, 1996, that translation of 0.93 kb testicular Sod1 transcript in the male gonads can be blocked by the 65 kDa protein, SOD-RBP (Cu,Zn-superoxide dismutase RNA-binding protein), which can be reversibly bound to the 5′UTR of the tSod1 mRNAs [78]. The authors suggest that SOD-RBP recognizes a secondary structure formed by 114 additional nucleotides within the 5′UTR of tSod1 [78]. However, expression and activity of SOD1 have been found in elongated spermatids and spermatozoa in humans, mice, and in other mammalian species [79,80,81,82,83,84]. Thus even if the expression of both 0.93 kb and, to a lesser extent, 0.80 kb Sod1 mRNAs in round spermatids was detected [77,78], they are translationally repressed and stored until the elongated spermatid stage. For normal activity, SOD1 needs to undergo maturation from apo-protein and monomer form to a functional dimeric holo-enzyme. During this process, apo-SOD1 requires zinc and copper and the formation of an intramolecular disulfide bond between two cysteines to form a homodimer [28,85]. SOD1 maturation is facilitated by CCS, which catalyzes the acquisition of Cu ions and the formation of a disulfide bond [27,28]. Thus, CCS plays a crucial role not only in SOD1 metalation but also in SOD1 activation.
In the absence of metal cofactors and upon reduction of the disulfide bonds, the SOD1 dimer is destabilized and exists as an inactive monomer. Only when both metal ions are present and a disulfide bond is formed, the active, dimeric form of SOD1 is stabilized [27,28,85]. Analysis of the expression of the Ccs gene in the testes of young (immature) and adult (mature) mice revealed that its mRNA abundance in the testes of young males is relatively low in comparison to mature animals [65]. This can be explained by the fact that in the testes of young animals, Ccs is expressed mainly in somatic cells, in which the translation of sSod1 takes place. Increased Ccs expression in the testes of adult males indicates that both Sod1 transcripts (sSod1 and tSod1 in germ cells) are translated to support an efficient metalation of both apo-forms of SOD1 [65].

7. Role of ATP7A, Copper Transporting ATPase in the Protection of Premeiotic and Meiotic Germ Cells from Copper Toxicity

An important question arises as to the mechanism of preventing germinal cells (and in general the gonads) from the toxic effects of copper excess. A possible explanation has been provided by the analysis of the expression of Cu-transporting ATPases: ATP7A and ATP7B proteins in the mouse testes [65]. Cu-transporting ATPases are the only proteins that control cellular copper efflux in mammals. The expression levels of ATP7A and ATP7B are tissue- and organ-dependent and in some organs developmentally regulated [3,10,11,33,34]. In seminiferous tubules, ATP7A is expressed in the spermatocytes [65]. Quantitative analysis of the expression of the Atp7A gene and ATP7A protein in mouse testes showed that the highest expression level of both gene and protein occurs in males between days 18 and 22 postpartum, when primary spermatocytes are the most prominent germ cells [65,86]. In the testes of adult mice, positive staining was observed in leptotene and pachytene spermatocytes but not in earlier or later stages of germ cells. Interestingly, the ATP7A protein has not been detected in the round and elongated spermatids [65]. All these data strongly suggest that the function of ATP7A is associated with the efflux of excess copper from male germ cells at the first prophase (mainly pachytene spermatocytes) to protect them against free radicals potentially generated by Cu ions. Indeed, increased copper concentration is toxic for germ cells because it contributes to oxidative damage to DNA including DNA oxidation, single and double-strand breaks, crosslinks and adducts, point mutations, and chromosome instability [87]. However, it is evident that copper cannot be excessively exported from germ cells because its appropriate level is required for meiotic division [66,68]. Immunohistochemical studies have revealed that expression of ATP7A protein within seminiferous tubuli is not restricted to germ cells, but is also present in somatic Sertoli cells [65]. In the Sertoli cells, the ATP7A protein is localized close to the basolateral part of the seminiferous tubuli, indicating that this protein is involved in copper efflux possibly contributing to the protection of these cells from copper overload. Previous findings have also shown that in polarized cells, increased intracellular copper levels trigger relocalization of ATP7A to the basolateral cell membrane [3]. Localization of ATP7A in the Sertoli cell can suggest that in the testes, this protein participates in the regulation of copper concentration not only in germ cells but also in seminiferous tubules. As demonstrated in mice with mutations in the Atp7a gene, copper concentration in the testes is higher than in the wild genotype (WT) controls, and this finding supports the concept of ATP7A as a protein playing a role in the maintenance of copper homeostasis in the testes [48]. In general, our knowledge regarding ATP7A function originates mostly from studies on mouse models with different mutations within the X-linked Atp7a gene, called mottled mutants [12,88,89,90,91]. To examine the role of ATP7A protein in the process of spermatogenesis, we used mice with the mosaic mutation (Atp7amo-ms) belonging to the group of mottled mouse models, recognized as animal models of Menkes disease [34,92]. In mosaic mice, the missense mutation c.2933G to C, in the Atp7a gene results in amino acid substitution Arg978Pro in the ATP7A protein [34]. Mosaic mutant males exhibit many clinical features characteristic for defective copper metabolism, including defects in pigmentation and hair structure, decrease in body weight, poor viability, and progressive paresis of the hind limbs. Similarly to other mottled mutants, mosaic mice exhibit disturbances in copper transport and absorption. In mutant males, copper is accumulated in the small intestine and kidneys, but the brain, liver, and heart have been found to be Cu-deficient [92,93,94]. Mutant males die at about days 16 postpartum, but if treated with subcutaneous injection of cupric chloride (CuCl2) solution, they survive longer and some of them achieve remarkable longevity [12,48]. Lack of activity of the ATP7A protein in mosaic mutants leads to the accumulation of copper in the testes, especially in mutant males treated with CuCl2 [48]. Copper accumulation in the gonads of the mutants results in increased apoptosis of the germ cells in both young and adult males [48,95]. In the testes of the adult mosaic mutants, apoptotic cells have frequently been identified among spermatocytes; for comparison, in mature testes of WT mice, sporadic apoptotic cell death is observed and apoptosis is largely restricted to spermatogonia [48,96]. This observation supports our findings showing that ATP7A activity in primary spermatocytes is of key importance for germ cells at the stage of the first prophase [65]. Histological analysis of the gonads from adult mutants has revealed gonad injury manifested as a presence of atrophic and vacuolated and in some males sclerotic seminiferous tubuli. Despite these abnormalities, spermatogenesis continues and mutant males produce spermatozoa [48,95]. Nevertheless, analysis of gamete quality has revealed a statistically significant decrease in the percentage of motile sperm, live spermatozoa, normal morphology, and spermatozoa tail membrane integrity in comparison with wild-type genotype control [48]. All the results confirm that ATP7A protein plays an important role in the process of spermatogenesis and lack of its activity leads to gonad injury and poor quality of gamete production. The expression and function of ATP7A protein in male mouse gonads is summarized in Table 1.

8. Role of the ATP7B Copper-Transporting ATPase in the Regulation of Copper Concentration in Postmeiotic Germ Cells

In the testes, in contrast to ATP7A, which is expressed in premeiotic and meiotic cells, ATP7B protein is located only in the postmeiotic germ cells—elongated spermatids. Moreover, ATP7B protein has been observed in elongated spermatids bound to Sertoli cells [65]. We postulate that in the elongated spermatids, ATP7B-bound copper in the Golgi apparatus can be transported with vesicles to the cytoplasm. This has been described for hepatocytes, in which increased copper concentration induces ATP7B trafficking from the TGN to a subset of lysosomes, where ATP7B imports copper into the lysosomal lumen and where the metal can be transiently stored [39]. It is possible that in elongated spermatids, the Cu-ATP7B complex is also transported to the lysosomal lumen and then removed from the cells with the residual cytoplasm, and can be engulfed by Sertoli cells [65]. In Sertoli cells, copper ions trapped in lysosomes might be taken up by the CTR2 transporter. Results of a quantitative analysis of the expression of the Slc31a2 and Atp7b genes have revealed that its expression significantly increases in the testes of 30-day-old male mice in which the process of spermiogenesis has started [65].
In the testes, ATP7B protein has also been found outside of seminiferous tubules in the myoid cells surrounding seminiferous tubuli, where the presence of CP has also been localized [65]. We postulate that in the myoid cells, ATP7B plays a biosynthetic role and participates in the binding of Cu+ ions to the apo-CP. In mammalian cells, CP is produced in two forms resulting from alternative splicing of exons 19 and 20 of the Cp gene [97]. The shorter form of CP, called a secretory CP, is the main protein transporting copper all over the organism, and is mainly produced by hepatocytes and secreted to the blood [97,98]. In the longer form of CP, the last five amino acids are replaced by 30 alternative residues, leading to the addition of the GPI (Glycosylphosphatidylinositol) anchor [97]. This GPI-CP form is located in the plasma membrane and plays the role of ferroxidase, which catalyzes the oxidation of Fe++ to Fe+++ and acts in conjunction with the only known mammalian iron exporter (ferroportin (FPN)) to mediate iron release from the cells. CP has been shown to co-localize with FPN within the cell membrane, forming a complex that allows Fe ions to be exported to the extracellular environment and to be loaded on transferrin, which binds only Fe+++ ions [99,100].
In the testes, expression of GPI-CP has previously been found in the Sertoli cells and it has been suggested that GPI-CP is related to transepithelial iron transport [101]. This suggestion is confirmed by a recent study showing that in the Sertoli cells, ferroportin is located in the basal membrane and it can participate in iron export from the seminiferous tubules [102]. In seminiferous tubules, both iron and copper should be kept at a low, physiologically constant level to protect the developing germ cells from copper/iron-induced oxidative damage. In conclusion, we suggest that the function of ATP7B in myoid cells might be associated with CP function and iron transport.
Copper transport in the male gonads and localization of the Cu-transporter in the seminiferous tubule are summarized in Table 1 and Figure 2.

9. Summary

Both copper deficiency and overload in the gonads are important conditions, which can negatively influence spermatozoa quality and reproductive function in humans and many other mammalian species [47,48,49,50,53,54,64]. Results of experiments conducted on model organisms such as yeast, insects, and mice have revealed that during the process of gamete production an appropriate copper level is necessary for meiosis progression and subsequent cell reorganization to form mature spermatozoa. However, the increased copper level is toxic to germ cells. Therefore, organisms have developed tightly regulated molecular mechanisms responsible for adequate copper supply to the gonads and its transport to Cu-dependent enzymes, but also for the protection of testes from the toxic effects of copper overload.

Author Contributions

Conceptualization, S.H., M.L., and P.L.; Writing—Original Draft Preparation, S.H., M.L., and P.L.; Writing—Review and Editing, P.G., A.B., R.S., and M.O.; Supervision, M.L. and P.L. All authors have read and agreed to the published version of the manuscript.

Funding

The open access publication of this article was founded by the Jagiellonian University partially by Grant DSC no. N18/MNW/000019 and by DS no. N18/DBW/000013.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Tümer, Z.; Møller, L.B. Menkes disease. Eur. J. Hum. Genet. 2010, 18, 511–518. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  2. Veldhuis, N.A.; Gaeth, A.P.; Pearson, R.B.; Gabriel, K.; Camakaris, J. The multi-layered regulation of copper translocating P-type ATPases. Biometals 2009, 22, 177–190. [Google Scholar] [CrossRef]
  3. Lutsenko, S.; Barnes, N.L.; Bartee, M.Y.; Dmitriev, O.Y. Function and regulation of human copper-transporting ATPases. Physiol. Rev. 2007, 87, 1011–1046. [Google Scholar] [CrossRef] [PubMed]
  4. Kodama, H.; Fujisawa, C.; Bhadhprasit, W. Inherited copper transport disorders: Biochemical mechanisms, diagnosis, and treatment. Curr. Drug Metab. 2012, 13, 237–250. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  5. Vashchenko, G.; MacGillivray, R.T.A. Multi-copper oxidases and human iron metabolism. Nutrients 2013, 5, 2289–2313. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  6. Gambling, L.; Kennedy, C.; McArdle, H.J. Iron and copper in fetal development. Semin. Cell Dev. Biol. 2011, 22, 637–644. [Google Scholar] [CrossRef] [PubMed]
  7. Van den Berghe, P.V.E.; Klomp, L.W.J. Posttranslational regulation of copper transporters. J. Biol. Inorg. Chem. 2010, 15, 37–46. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  8. Turnlund, J.R. Human whole-body copper metabolism. Am. J. Clin. Nutr. 1998, 67, 960S–964S. [Google Scholar] [CrossRef] [Green Version]
  9. Bartee, M.Y.; Lutsenko, S. Hepatic copper-transporting ATPase ATP7B: Function and inactivation at the molecular and cellular level. Biometals 2007, 20, 627–637. [Google Scholar] [CrossRef]
  10. Lenartowicz, M.; Wieczerzak, K.; Krzeptowski, W.; Dobosz, P.; Grzmil, P.; Starzynski, R.; Lipinski, P. Developmental changes in the expression of the Atp7a gene in the liver of mice during the postnatal period. J. Exp. Zool. A Ecol. Genet. Physiol. 2010, 313, 209–217. [Google Scholar]
  11. Linz, R.; Barnes, N.L.; Zimnicka, A.M.; Kaplan, J.H.; Eipper, B.; Lutsenko, S. Intracellular targeting of copper-transporting ATPase ATP7A in a normal and Atp7b-/- kidney. Am. J. Physiol. Ren. Physiol. 2008, 294, F53–F61. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  12. Lenartowicz, M.; Windak, R.; Tylko, G.; Kowal, M.; Styrna, J. Effects of copper supplementation on the structure and content of elements in kidneys of mosaic mutant mice. Biol. Trace Elem. Res. 2010, 136, 204–220. [Google Scholar] [CrossRef] [PubMed]
  13. Mercer, J.F.; Livingston, J.; Hall, B.; Paynter, J.A.; Begy, C.; Chandrasekharappa, S.; Lockhart, P.; Grimes, A.; Bhave, M.; Siemieniak, D. Isolation of a partial candidate gene for Menkes disease by positional cloning. Nat. Genet. 1993, 3, 20–25. [Google Scholar] [CrossRef] [PubMed]
  14. Chelly, J.; Tumer, Z.; Tonnesen, T.; Petterson, A.; Ishikawa-Brush, Y.; Tommerup, N.; Horn, N.; Monaco, A.P. Isolation of a candidate gene for Menkes disease that encodes a potential heavy metal binding protein. Nat. Genet. 1993, 3, 14–19. [Google Scholar] [CrossRef] [PubMed]
  15. Vulpe, C.; Levinson, B.; Whitney, S.; Packman, S.; Gitschier, J. Isolation of a candidate gene for Menkes disease and evidence that it encodes a copper-transporting ATPase. Nat. Genet. 1993, 3, 7–13. [Google Scholar] [CrossRef] [PubMed]
  16. Bull, P.C.; Thomas, G.R.; Rommens, J.M.; Forbes, J.R.; Cox, D.W. The Wilson disease gene is a putative copper transporting P-type ATPase similar to the Menkes gene. Nat. Genet. 1993, 5, 327–337. [Google Scholar] [CrossRef]
  17. Gupta, A.; Lutsenko, S. Human copper transporters: Mechanism, role in human diseases and therapeutic potential. Future Med. Chem. 2009, 1, 1125–1142. [Google Scholar] [CrossRef] [Green Version]
  18. Nevitt, T.; Ohrvik, H.; Thiele, D.J. Charting the travels of copper in eukaryotes from yeast to mammals. Biochim. Biophys. Acta 2012, 1823, 1580–1593. [Google Scholar] [CrossRef] [Green Version]
  19. Kuo, Y.-M.; Gybina, A.A.; Pyatskowit, J.W.; Gitschier, J.; Prohaska, J.R. Copper transport protein (Ctr1) levels in mice are tissue specific and dependent on copper status. J. Nutr. 2006, 136, 21–26. [Google Scholar] [CrossRef] [Green Version]
  20. Öhrvik, H.; Nose, Y.; Wood, L.K.; Kim, B.-E.; Gleber, S.-C.; Ralle, M.; Thiele, D.J. Ctr2 regulates biogenesis of a cleaved form of mammalian Ctr1 metal transporter lacking the copper- and cisplatin-binding ecto-domain. Proc. Natl. Acad. Sci. USA 2013, 110, E4279–E4288. [Google Scholar] [CrossRef] [Green Version]
  21. Aller, S.G.; Unger, V.M. Projection structure of the human copper transporter CTR1 at 6-A resolution reveals a compact trimer with a novel channel-like architecture. Proc. Natl. Acad. Sci. USA 2006, 103, 3627–3632. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  22. Guo, Y.; Smith, K.; Lee, J.; Thiele, D.J.; Petris, M.J. Identification of methionine-rich clusters that regulate copper- stimulated endocytosis of the human Ctr1 copper transporter. J. Biol. Chem. 2004, 279, 17428–17433. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  23. Wee, N.K.Y.; Weinstein, D.C.; Fraser, S.T.; Assinder, S.J. The mammalian copper transporters CTR1 and CTR2 and their roles in development and disease. Int. J. Biochem. Cell Biol. 2013, 45, 960–963. [Google Scholar] [CrossRef] [PubMed]
  24. Lutsenko, S.; Tsivkovskii, R.; Walker, J.M. Functional properties of the human copper-transporting ATPase ATP7B (the Wilson’s disease protein) and regulation by metallochaperone Atox1. Ann. N. Y. Acad. Sci. 2003, 986, 204–211. [Google Scholar] [CrossRef]
  25. Barry, A.N.; Shinde, U.; Lutsenko, S. Structural organization of human Cu-transporting ATPases: Learning from building blocks. J. Biol. Inorg. Chem. 2010, 15, 47–59. [Google Scholar] [CrossRef]
  26. Rae, T.D.; Torres, A.S.; Pufahl, R.A.; O’Halloran, T.V. Mechanism of Cu,Zn-superoxide dismutase activation by the human metallochaperone hCCS. J. Biol. Chem. 2001, 276, 5166–5176. [Google Scholar] [CrossRef] [Green Version]
  27. Prohaska, J.R.; Geissler, J.; Brokate, B.; Broderius, M. Copper, zinc-superoxide dismutase protein but not mRNA is lower in copper-deficient mice and mice lacking the copper chaperone for superoxide dismutase. Exp. Biol. Med. 2003, 228, 959–966. [Google Scholar] [CrossRef]
  28. Wong, P.C.; Waggoner, D.; Subramaniam, J.R.; Tessarollo, L.; Bartnikas, T.B.; Culotta, V.C.; Price, D.L.; Rothstein, J.; Gitlin, J.D. Copper chaperone for superoxide dismutase is essential to activate mammalian Cu/Zn superoxide dismutase. Proc. Natl. Acad. Sci. USA 2000, 97, 2886–2891. [Google Scholar] [CrossRef] [Green Version]
  29. Casareno, R.L.; Waggoner, D.; Gitlin, J.D. The copper chaperone CCS directly interacts with copper/zinc superoxide dismutase. J. Biol. Chem. 1998, 273, 23625–23628. [Google Scholar] [CrossRef] [Green Version]
  30. Kako, K.; Tsumori, K.; Ohmasa, Y.; Takahashi, Y.; Munekata, E. The expression of Cox17p in rodent tissues and cells. Eur. J. Biochem. 2000, 267, 6699–6707. [Google Scholar] [CrossRef] [Green Version]
  31. Prohaska, J.R.; Gybina, A.A. Intracellular copper transport in mammals. J. Nutr. 2004, 134, 1003–1006. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  32. Linz, R.; Lutsenko, S. Copper-transporting ATPases ATP7A and ATP7B: Cousins, not twins. J. Bioenerg. Biomembr. 2007, 39, 403–407. [Google Scholar] [CrossRef] [PubMed]
  33. Lenartowicz, M.; Kennedy, C.; Hayes, H.; McArdle, H.J. Transcriptional regulation of copper metabolism genes in the liver of fetal and neonatal control and iron-deficient rats. Biometals 2015, 28, 51–59. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  34. Lenartowicz, M.; Starzynski, R.; Wieczerzak, K.; Krzeptowski, W.; Lipinski, P.; Styrna, J. Alterations in the expression of the Atp7a gene in the early postnatal development of the mosaic mutant mice (Atp7a mo-ms)—An animal model for Menkes disease. Gene Expr. Patterns 2011, 11, 41–47. [Google Scholar] [CrossRef]
  35. Lutsenko, S.; Gupta, A.; Burkhead, J.L.; Zuzel, V. Cellular multitasking: The dual role of human Cu-ATPases in cofactor delivery and intracellular copper balance. Arch. Biochem. Biophys. 2008, 476, 22–32. [Google Scholar] [CrossRef] [Green Version]
  36. Moore, S.D.P.; Cox, D.W. Expression in mouse kidney of membrane copper transporters Atp7a and Atp7b. Nephron 2002, 92, 629–634. [Google Scholar] [CrossRef]
  37. Bull, P.C.; Cox, D.W. Long range restriction mapping of 13q14.3 focused on the Wilson disease region. Genomics 1993, 16, 593–598. [Google Scholar] [CrossRef]
  38. La Fontaine, S.; Mercer, J.F.B. Trafficking of the copper-ATPases, ATP7A and ATP7B: Role in copper homeostasis. Arch. Biochem. Biophys. 2007, 463, 149–167. [Google Scholar] [CrossRef]
  39. Polishchuk, E.V.; Concilli, M.; Iacobacci, S.; Chesi, G.; Pastore, N.; Piccolo, P.; Paladino, S.; Baldantoni, D.; van IJzendoorn, S.C.D.; Chan, J.; et al. Wilson disease protein ATP7B utilizes lysosomal exocytosis to maintain copper homeostasis. Dev. Cell 2014, 29, 686–700. [Google Scholar] [CrossRef] [Green Version]
  40. Hardman, B.; Manuelpillai, U.; Wallace, E.M.; van de Waasenburg, S.; Cater, M.; Mercer, J.F.B.; Ackland, M.L. Expression and localization of menkes and Wilson copper transporting ATPases in human placenta. Placenta 2004, 25, 512–517. [Google Scholar] [CrossRef] [Green Version]
  41. Hardman, B.; Luff, S.; Ackland, M.L. Differential intracellular localisation of the Menkes and Wilson copper transporting ATPases in the third trimester human placenta. Placenta 2011, 32, 79–85. [Google Scholar] [CrossRef] [PubMed]
  42. Michalczyk, A.A.; Rieger, J.; Allen, K.J.; Mercer, J.F.; Ackland, M.L. Defective localization of the Wilson disease protein (ATP7B) in the mammary gland of the toxic milk mouse and the effects of copper supplementation. Biochem. J. 2000, 352 Pt 2, 565–571. [Google Scholar] [CrossRef]
  43. Lutsenko, S. Modifying factors and phenotypic diversity in Wilson’s disease. Ann. N. Y. Acad. Sci. 2014, 1315, 56–63. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  44. Mercer, J.F.B.; Barnes, N.; Stevenson, J.; Strausak, D.; Llanos, R.M. Copper-induced trafficking of the cU-ATPases: A key mechanism for copper homeostasis. Biometals 2003, 16, 175–184. [Google Scholar] [CrossRef] [PubMed]
  45. Petris, M.J.; Strausak, D.; Mercer, J.F. The Menkes copper transporter is required for the activation of tyrosinase. Hum. Mol. Genet. 2000, 9, 2845–2851. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  46. Qin, Z.; Itoh, S.; Jeney, V.; Ushio-Fukai, M.; Fukai, T. Essential role for the Menkes ATPase in activation of extracellular superoxide dismutase: Implication for vascular oxidative stress. FASEB J. 2006, 20, 334–336. [Google Scholar] [CrossRef] [PubMed]
  47. Chen, H.; Kang, Z.; Qiao, N.; Liu, G.; Huang, K.; Wang, X.; Pang, C.; Zeng, Q.; Tang, Z.; Li, Y. Chronic Copper Exposure Induces Hypospermatogenesis in Mice by Increasing Apoptosis Without Affecting Testosterone Secretion. Biol. Trace Elem. Res. 2020, 195, 472–480. [Google Scholar] [CrossRef]
  48. Kowal, M.; Lenartowicz, M.; Pecio, A.; Golas, A.; Blaszkiewicz, T.; Styrna, J. Copper metabolism disorders affect testes structure and gamete quality in male mice. Syst. Biol. Reprod. Med. 2010, 56, 431–444. [Google Scholar] [CrossRef] [Green Version]
  49. Liu, J.Y.; Yang, X.; Sun, X.D.; Zhuang, C.C.; Xu, F.B.; Li, Y.F. Suppressive Effects of Copper Sulfate Accumulation on the Spermatogenesis of Rats. Biol. Trace Elem. Res. 2016, 174, 356–361. [Google Scholar] [CrossRef]
  50. Tvrda, E.; Peer, R.; Sikka, S.C.; Agarwal, A. Iron and copper in male reproduction: A double-edged sword. J. Assist. Reprod. Genet. 2015, 32, 3–16. [Google Scholar] [CrossRef] [Green Version]
  51. Kheirandish, R.; Askari, N.; Babaei, H. Zinc therapy improves deleterious effects of chronic copper administration on mice testes: Histopathological evaluation. Andrologia 2014, 46, 80–85. [Google Scholar] [CrossRef] [PubMed]
  52. Chattopadhyay, A.; Sarkar, M.; Biswas, N.M. Dose-dependent effect of copper chloride on male reproductive function in immature rats. Kathmandu Univ. Med. J. (KUMJ) 2005, 3, 392–400. [Google Scholar]
  53. Akinloye, O.; Abbiyesuku, F.M.; Oguntibeju, O.O.; Arowojolu, A.O.; Truter, E.J. The impact of blood and seminal plasma zinc and copper concentrations on spermogram and hormonal changes in infertile Nigerian men. Reprod. Biol. 2011, 11, 83–98. [Google Scholar] [CrossRef]
  54. Aydemir, B.; Kiziler, A.R.; Onaran, I.; Alici, B.; Ozkara, H.; Akyolcu, M.C. Impact of Cu and Fe concentrations on oxidative damage in male infertility. Biol. Trace Elem. Res. 2006, 112, 193–203. [Google Scholar] [CrossRef]
  55. Roychoudhury, S.; Nath, S.; Massanyi, P.; Stawarz, R.; Kacaniova, M.; Kolesarova, A. Copper-induced changes in reproductive functions: In vivo and in vitro effects. Physiol. Res. 2016, 65, 11–22. [Google Scholar] [CrossRef]
  56. Kasperczyk, A.; Dobrakowski, M.; Czuba, Z.P.; Kapka-Skrzypczak, L.; Kasperczyk, S. Environmental exposure to zinc and copper influences sperm quality in fertile males. Ann. Agric. Environ. Med. 2016, 23, 138–143. [Google Scholar] [CrossRef]
  57. Roblero, L.; Guadarrama, A.; Lopez, T.; Zegers-Hochschild, F. Effect of copper ion on the motility, viability, acrosome reaction and fertilizing capacity of human spermatozoa in vitro. Reprod. Fertil. Dev. 1996, 8, 871–874. [Google Scholar] [CrossRef]
  58. Aupperle, H.; Schoon, H.A.; Frank, A. Experimental copper deficiency, chromium deficiency and additional molybdenum supplementation in goats--pathological findings. Acta Vet. Scand. 2001, 42, 311–321. [Google Scholar] [CrossRef]
  59. Lyubimov, A.V.; Smith, J.A.; Rousselle, S.D.; Mercieca, M.D.; Tomaszewski, J.E.; Smith, A.C.; Levine, B.S. The effects of tetrathiomolybdate (TTM, NSC-714598) and copper supplementation on fertility and early embryonic development in rats. Reprod. Toxicol. 2004, 19, 223–233. [Google Scholar] [CrossRef]
  60. Van Niekerk, F.E.; Van Niekerk, C.H. The influence of experimentally induced copper deficiency on the fertility of rams. I. Semen parameters and peripheral plasma androgen concentration. J. S. Afr. Vet. Assoc. 1989, 60, 28–31. [Google Scholar]
  61. Van Niekerk, F.E.; Van Niekerk, C.H. The influence of experimentally induced copper deficiency on the fertility of rams. II. Macro- and microscopic changes in the testes. J. S. Afr. Vet. Assoc. 1989, 60, 32–35. [Google Scholar]
  62. Yang, H.; Brosel, S.; Acin-Perez, R.; Slavkovich, V.; Nishino, I.; Khan, R.; Goldberg, I.J.; Graziano, J.; Manfredi, G.; Schon, E.A. Analysis of mouse models of cytochrome c oxidase deficiency owing to mutations in Sco2. Hum. Mol. Genet. 2010, 19, 170–180. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  63. Cheng, C.Y.; Mruk, D.D. The blood-testis barrier and its implications for male contraception. Pharmacol. Rev. 2012, 64, 16–64. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  64. Ghaffari, R.; Di Bona, K.R.; Riley, C.L.; Richburg, J.H. Copper transporter 1 (CTR1) expression by mouse testicular germ cells, but not Sertoli cells, is essential for functional spermatogenesis. PLoS ONE 2019, 14, e0215522. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  65. Ogórek, M.; Lenartowicz, M.; Starzyński, R.; Jończy, A.; Staroń, R.; Doniec, A.; Krzeptowski, W.; Bednarz, A.; Pierzchała, O.; Lipiński, P.; et al. Atp7a and Atp7b regulate copper homeostasis in developing male germ cells in mice. Metallomics 2017, 9, 1288–1303. [Google Scholar] [CrossRef] [PubMed]
  66. Beaudoin, J.; Ioannoni, R.; Normant, V.; Labbe, S. A role for the transcription factor Mca1 in activating the meiosis- specific copper transporter Mfc1. PLoS ONE 2018, 13, e0201861. [Google Scholar] [CrossRef] [PubMed]
  67. Beaudoin, J.; Thiele, D.J.; Labbe, S.; Puig, S. Dissection of the relative contribution of the Schizosaccharomyces pombe Ctr4 and Ctr5 proteins to the copper transport and cell surface delivery functions. Microbiology 2011, 157, 1021–1031. [Google Scholar] [CrossRef] [Green Version]
  68. Plante, S.; Ioannoni, R.; Beaudoin, J.; Labbe, S. Characterization of Schizosaccharomyces pombe copper transporter proteins in meiotic and sporulating cells. J. Biol. Chem. 2014, 289, 10168–10181. [Google Scholar] [CrossRef] [Green Version]
  69. Beaudoin, J.; Ioannoni, R.; Labbe, S. Mfc1 is a novel copper transporter during meiosis. Commun. Integr. Biol. 2012, 5, 118–121. [Google Scholar] [CrossRef]
  70. Beaudoin, J.; Ekici, S.; Daldal, F.; Ait-Mohand, S.; Guerin, B.; Labbe, S. Copper transport and regulation in Schizosaccharomyces pombe. Biochem. Soc. Trans. 2013, 41, 1679–1686. [Google Scholar] [CrossRef] [Green Version]
  71. Steiger, D.; Fetchko, M.; Vardanyan, A.; Atanesyan, L.; Steiner, K.; Turski, M.L.; Thiele, D.J.; Georgiev, O.; Schaffner, W. The Drosophila copper transporter Ctr1C functions in male fertility. J. Biol. Chem. 2010, 285, 17089–17097. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  72. Skandhan, K.P. Review on copper in male reproduction and contraception. Rev. Française Gynécologie D’obstétrique 1992, 87, 594–598. [Google Scholar]
  73. Celino, F.T.; Yamaguchi, S.; Miura, C.; Ohta, T.; Tozawa, Y.; Iwai, T.; Miura, T. Tolerance of spermatogonia to oxidative stress is due to high levels of Zn and Cu/Zn superoxide dismutase. PLoS ONE 2011, 6, e16938. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  74. Aitken, R.J. Reactive oxygen species as mediators of sperm capacitation and pathological damage. Mol. Reprod. Dev. 2017, 84, 1039–1052. [Google Scholar] [CrossRef]
  75. Trist, B.; Hilton, J.B.; Crouch, P.J.; Hare, D.J.; Double, K.L. Superoxide dismutase 1 in health and disease: How a front-line antioxidant becomes neurotoxic. Angew. Chem. Int. Ed. Engl. 2020. [Google Scholar] [CrossRef]
  76. Lopes, I.M.D.; de Oliveira, I.M.; Bargi-Souza, P.; Cavallin, M.D.; Kolc, C.S.M.; Khalil, N.M.; Quinaia, S.P.; Romano, M.A.; Romano, R.M. Effects of Silver Nanoparticle Exposure to the Testicular Antioxidant System during the Prepubertal Rat Stage. Chem. Res. Toxicol. 2019, 32, 986–994. [Google Scholar] [CrossRef]
  77. Gu, W.; Morales, C.; Hecht, N.B. In male mouse germ cells, copper-zinc superoxide dismutase utilizes alternative promoters that produce multiple transcripts with different translation potential. J. Biol. Chem. 1995, 270, 236–243. [Google Scholar] [CrossRef] [Green Version]
  78. Gu, W.; Hecht, N.R. Translation of a testis-specific Cu/Zn superoxide dismutase (SOD-1) mRNA is regulated by a 65-kilodalton protein which binds to its 5’ untranslated region. Mol. Cell. Biol. 1996, 16, 4535–4543. [Google Scholar] [CrossRef] [Green Version]
  79. Ogórek, M.; Herman, S.; Pierzchała, O.; Bednarz, A.; Rajfur, Z.; Baster, Z.; Grzmil, P.; Starzyński, R.R.; Szudzik, M.; Jończy, A.; et al. Molecular machinery providing copper bioavailability for spermatozoa along the epididymial tubule in mouse. Biol. Reprod. 2019, 100, 1505–1520. [Google Scholar] [CrossRef]
  80. Aitken, R.J.; Buckingham, D.W.; Carreras, A.; Irvine, D.S. Superoxide dismutase in human sperm suspensions: Relationship with cellular composition, oxidative stress, and sperm function. Free Radic. Biol. Med. 1996, 21, 495–504. [Google Scholar] [CrossRef]
  81. Buffone, M.G.; Calamera, J.C.; Brugo-Olmedo, S.; De Vincentiis, S.; Calamera, M.M.; Storey, B.T.; Doncel, G.F.; Alvarez, J.G. Superoxide dismutase content in sperm correlates with motility recovery after thawing of cryopreserved human spermatozoa. Fertil. Steril. 2012, 97, 293–298. [Google Scholar] [CrossRef] [PubMed]
  82. Koziorowska-Gilun, M.; Koziorowski, M.; Fraser, L.; Strzezek, J. Antioxidant defence system of boar cauda epididymidal spermatozoa and reproductive tract fluids. Reprod. Domest. Anim. 2011, 46, 527–533. [Google Scholar] [CrossRef] [PubMed]
  83. Park, K.; Jeon, S.; Song, Y.-J.; Yi, L.S.H. Proteomic analysis of boar spermatozoa and quantity changes of superoxide dismutase 1, glutathione peroxidase, and peroxiredoxin 5 during epididymal maturation. Anim. Reprod. Sci. 2012, 135, 53–61. [Google Scholar] [CrossRef] [PubMed]
  84. Grant, K.E.; de Oliveira, R.V.; Hennington, B.S.; Govindaraju, A.; Perkins, A.; Stokes, J.; Rowe, D.; Topper, E.; Kaya, A.; Moura, A.; et al. Sperm superoxide dismutase is associated with bull fertility. Reprod. Fertil. Dev. 2015. [Google Scholar] [CrossRef] [PubMed]
  85. Antinone, S.E.; Ghadge, G.D.; Ostrow, L.W.; Roos, R.P.; Green, W.N. S-acylation of SOD1, CCS, and a stable SOD1-CCS heterodimer in human spinal cords from ALS and non-ALS subjects. Sci. Rep. 2017, 7, 41141. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  86. Montoto, L.G.; Arregui, L.; Sanchez, N.M.; Gomendio, M.; Roldan, E.R.S. Postnatal testicular development in mouse species with different levels of sperm competition. Reproduction 2012, 143, 333–346. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  87. Linder, M.C. The relationship of copper to DNA damage and damage prevention in humans. Mutat. Res. 2012, 733, 83–91. [Google Scholar] [CrossRef]
  88. Lenartowicz, M.; Krzeptowski, W.; Lipinski, P.; Grzmil, P.; Starzynski, R.; Pierzchala, O.; Moller, L.B. Mottled Mice and Non-Mammalian Models of Menkes Disease. Front. Mol. Neurosci. 2015, 8, 72. [Google Scholar] [CrossRef] [Green Version]
  89. La Fontaine, S.; Firth, S.D.; Lockhart, P.J.; Brooks, H.; Camakaris, J.; Mercer, J.F. Intracellular localization and loss of copper responsiveness of Mnk, the murine homologue of the Menkes protein, in cells from blotchy (Mo blo) and brindled (Mo br) mouse mutants. Hum. Mol. Genet. 1999, 8, 1069–1075. [Google Scholar] [CrossRef] [Green Version]
  90. Niciu, M.J.; Ma, X.-M.; El Meskini, R.; Pachter, J.S.; Mains, R.E.; Eipper, B.A. Altered ATP7A expression and other compensatory responses in a murine model of Menkes disease. Neurobiol. Dis. 2007, 27, 278–291. [Google Scholar] [CrossRef] [Green Version]
  91. Kodama, H.; Abe, T.; Takama, M.; Takahashi, I.; Kodama, M.; Nishimura, M. Histochemical localization of copper in the intestine and kidney of macular mice: Light and electron microscopic study. J. Histochem. Cytochem. 1993, 41, 1529–1535. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  92. Styrna, J. Analysis of causes of lethality in mice with the Ms (Mosaic) gene. Genet. Pol. 1977, 18, 61–79. [Google Scholar]
  93. Lenartowicz, M.; Sasuła, K. Altered copper metabolism in the Mosaic mutant mice. Nutr. Res. 2000, 20, 1467–1471. [Google Scholar] [CrossRef]
  94. Lenartowicz, M.; Kowal, M.; Buda-Lewandowska, D.; Styrna, J. Pathological structure of the kidney from adult mice with mosaic mutation. J. Inherit. Metab. Dis. 2002, 25, 647–659. [Google Scholar] [CrossRef]
  95. Kotula-Balak, M.; Lenartowicz, M.; Kowal, M.; Styrna, J.; Bilinska, B. Testicular morphology and expression of aromatase in testes of mice with the mosaic mutation (Atp7a mo-ms). Theriogenology 2007, 67, 423–434. [Google Scholar] [CrossRef]
  96. Rodriguez, I.; Ody, C.; Araki, K.; Garcia, I.; Vassalli, P. An early and massive wave of germinal cell apoptosis is required for the development of functional spermatogenesis. EMBO J. 1997, 16, 2262–2270. [Google Scholar] [CrossRef] [Green Version]
  97. Patel, B.N.; Dunn, R.J.; David, S. Alternative RNA splicing generates a glycosylphosphatidylinositol- anchored form of ceruloplasmin in mammalian brain. J. Biol. Chem. 2000, 275, 4305–4310. [Google Scholar] [CrossRef] [Green Version]
  98. Ramos, D.; Mar, D.; Ishida, M.; Vargas, R.; Gaite, M.; Montgomery, A.; Linder, M.C. Mechanism of Copper Uptake from Blood Plasma Ceruloplasmin by Mammalian Cells. PLoS ONE 2016, 11, e0149516. [Google Scholar] [CrossRef] [Green Version]
  99. Drakesmith, H.; Nemeth, E.; Ganz, T. Ironing out Ferroportin. Cell Metab. 2015, 22, 777–787. [Google Scholar] [CrossRef] [Green Version]
  100. De Domenico, I.; Ward, D.M.; di Patti, M.C.B.; Jeong, S.Y.; David, S.; Musci, G.; Kaplan, J. Ferroxidase activity is required for the stability of cell surface ferroportin in cells expressing GPI-ceruloplasmin. EMBO J. 2007, 26, 2823–2831. [Google Scholar] [CrossRef]
  101. Fortna, R.R.; Watson, H.A.; Nyquist, S.E. Glycosyl phosphatidylinositol-anchored ceruloplasmin is expressed by rat Sertoli cells and is concentrated in detergent-insoluble membrane fractions. Biol. Reprod. 1999, 61, 1042–1049. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  102. Leichtmann-Bardoogo, Y.; Cohen, L.A.; Weiss, A.; Marohn, B.; Schubert, S.; Meinhardt, A.; Meyron-Holtz, E.G. Compartmentalization and regulation of iron metabolism proteins protect male germ cells from iron overload. Am. J. Physiol. Endocrinol. Metab. 2012, 302, E1519–E1530. [Google Scholar] [CrossRef] [PubMed] [Green Version]
Ijms 21 09053 g001 550
Figure 1. Copper metabolism in polarized mammalian cells. Cupric ions (Cu2+) are reduced to cuprous ions (Cu+) by metaloreductase and can then be transported into the cell by the transmembrane transporters CTR1 or CTR2. In the cytosol, Cu+ ions can be reversibly bound by metallothionein (MT) and stored in the Cu-MT complex. In the cytoplasm Cu+ ions are bound by cytosolic metallochaperones: copper chaperone for superoxide dismutase 1 (CCS), COX17, and ATOX1, which deliver copper to various proteins such as superoxide dismutase 1 (SOD1), cytochrome c oxidase (CCO), ATP7A, and ATP7B. As a result, copper is delivered to different cellular compartments such as the cytoplasmic reticulum, mitochondria, or the Golgi apparatus. The ATP7A and ATP7B proteins located in the trans-Golgi network (TGN) incorporate Cu+ ions into the apoenzymes. ATP7B can transfer copper to apo-ceruloplasmin (CP) to form holo-ceruloplasmin. Then copper in the complex with ceruloplasmin can be transported to the blood vessels. Cu-transporting ATPases can remove the excess copper outside the cell: ATP7A across the basolateral membrane and ATP7B across the apical membrane of polarized cells. This figure was created with BioRender.com.
Figure 1. Copper metabolism in polarized mammalian cells. Cupric ions (Cu2+) are reduced to cuprous ions (Cu+) by metaloreductase and can then be transported into the cell by the transmembrane transporters CTR1 or CTR2. In the cytosol, Cu+ ions can be reversibly bound by metallothionein (MT) and stored in the Cu-MT complex. In the cytoplasm Cu+ ions are bound by cytosolic metallochaperones: copper chaperone for superoxide dismutase 1 (CCS), COX17, and ATOX1, which deliver copper to various proteins such as superoxide dismutase 1 (SOD1), cytochrome c oxidase (CCO), ATP7A, and ATP7B. As a result, copper is delivered to different cellular compartments such as the cytoplasmic reticulum, mitochondria, or the Golgi apparatus. The ATP7A and ATP7B proteins located in the trans-Golgi network (TGN) incorporate Cu+ ions into the apoenzymes. ATP7B can transfer copper to apo-ceruloplasmin (CP) to form holo-ceruloplasmin. Then copper in the complex with ceruloplasmin can be transported to the blood vessels. Cu-transporting ATPases can remove the excess copper outside the cell: ATP7A across the basolateral membrane and ATP7B across the apical membrane of polarized cells. This figure was created with BioRender.com.
Ijms 21 09053 g001
Ijms 21 09053 g002 550
Figure 2. Localization of copper-related proteins in the seminiferous tubule and myoid cells. In the testes, gametes are produced during the multi-step process called spermatogenesis, which covers a complex network of regulations that occur in the seminiferous tubules. Each seminiferous tubule is surrounded by a few layers of myoid cells that border on blood vessels. The seminiferous epithelium contains the Sertoli cells and the germ cells and lies on the basal lamina. The lumen of the seminiferous tubule is filled with seminal fluid. The Sertoli cells are polarized cells that reach the lumen of the seminiferous tubule and support the individual stages of developing germ cells. Sertoli cells are linked by tight junctions that form a blood–testis barrier. This divides the seminiferous epithelium into the adluminal and basal compartments and allows Sertoli cells to control the environment for developing late germ cells. The first stages of the germ cell line are spermatogonia, which lie on the basal lamina. Above them, primary and secondary spermatocytes are successively situated. The next stages are round spermatids, which transform into elongated spermatids. After absorption of residual bodies, Sertoli cells release the elongated spermatids into the seminiferous tubule lumen where these spermatids become sperm. The transport of Cu ions during the process of spermatogenesis occurs between germ cells, Sertoli cells, and myoid cells. Spermatogonia, primary spermatocytes, and Sertoli cells absorb copper using CTR1. The excess copper is exported from the primary spermatocytes and Sertoli cells through the ATP7A protein. Presumably, a similar function is performed by ATP7B in the elongated spermatids. Removed Cu+ ions are imported to Sertoli cells through CTR1. In Sertoli cells and myoid cells, copper is delivered to the ceruloplasmin via ATP7B. In the complex with ceruloplasmin, Cu+ ions leave the myoid cells and enter the bloodstream. This figure was created with BioRender.com.
Figure 2. Localization of copper-related proteins in the seminiferous tubule and myoid cells. In the testes, gametes are produced during the multi-step process called spermatogenesis, which covers a complex network of regulations that occur in the seminiferous tubules. Each seminiferous tubule is surrounded by a few layers of myoid cells that border on blood vessels. The seminiferous epithelium contains the Sertoli cells and the germ cells and lies on the basal lamina. The lumen of the seminiferous tubule is filled with seminal fluid. The Sertoli cells are polarized cells that reach the lumen of the seminiferous tubule and support the individual stages of developing germ cells. Sertoli cells are linked by tight junctions that form a blood–testis barrier. This divides the seminiferous epithelium into the adluminal and basal compartments and allows Sertoli cells to control the environment for developing late germ cells. The first stages of the germ cell line are spermatogonia, which lie on the basal lamina. Above them, primary and secondary spermatocytes are successively situated. The next stages are round spermatids, which transform into elongated spermatids. After absorption of residual bodies, Sertoli cells release the elongated spermatids into the seminiferous tubule lumen where these spermatids become sperm. The transport of Cu ions during the process of spermatogenesis occurs between germ cells, Sertoli cells, and myoid cells. Spermatogonia, primary spermatocytes, and Sertoli cells absorb copper using CTR1. The excess copper is exported from the primary spermatocytes and Sertoli cells through the ATP7A protein. Presumably, a similar function is performed by ATP7B in the elongated spermatids. Removed Cu+ ions are imported to Sertoli cells through CTR1. In Sertoli cells and myoid cells, copper is delivered to the ceruloplasmin via ATP7B. In the complex with ceruloplasmin, Cu+ ions leave the myoid cells and enter the bloodstream. This figure was created with BioRender.com.
Ijms 21 09053 g002
Table
Table 1. The functions of copper-dependent proteins in the particular germ and somatic cells in the male mouse gonad.
Table 1. The functions of copper-dependent proteins in the particular germ and somatic cells in the male mouse gonad.
Cell
Type		Germ CellsSomatic Cells
Protein Ijms 21 09053 i001 Ijms 21 09053 i002 Ijms 21 09053 i003 Ijms 21 09053 i004 Ijms 21 09053 i005
CTR1Cu transport to the cellCu transport to the cellNot foundCu transport to the cellCu transport to the cell?
ATP7ANot foundCellular Cu efflux and protection of cells from copper overloadNot foundCellular Cu efflux and protection of cells from copper overloadNot found
ATP7BNot foundNot foundCellular Cu efflux and protection of cells from copper overloadCP metalationCP metalation
SOD1Antioxidant protectionNot foundAntioxidant protectionAntioxidant protectionNot found
CPNot foundNot foundNot foundOxidation of Fe++ ions? Cu+ ions sequestering?Oxidation of Fe++ ions
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Herman, S.; Lipiński, P.; Ogórek, M.; Starzyński, R.; Grzmil, P.; Bednarz, A.; Lenartowicz, M. Molecular Regulation of Copper Homeostasis in the Male Gonad during the Process of Spermatogenesis. Int. J. Mol. Sci. 2020, 21, 9053. https://0-doi-org.brum.beds.ac.uk/10.3390/ijms21239053

AMA Style

Herman S, Lipiński P, Ogórek M, Starzyński R, Grzmil P, Bednarz A, Lenartowicz M. Molecular Regulation of Copper Homeostasis in the Male Gonad during the Process of Spermatogenesis. International Journal of Molecular Sciences. 2020; 21(23):9053. https://0-doi-org.brum.beds.ac.uk/10.3390/ijms21239053

Chicago/Turabian Style

Herman, Sylwia, Paweł Lipiński, Mateusz Ogórek, Rafał Starzyński, Paweł Grzmil, Aleksandra Bednarz, and Małgorzata Lenartowicz. 2020. "Molecular Regulation of Copper Homeostasis in the Male Gonad during the Process of Spermatogenesis" International Journal of Molecular Sciences 21, no. 23: 9053. https://0-doi-org.brum.beds.ac.uk/10.3390/ijms21239053

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop